AQUA PHARMA AS

2624 LILLEHAMMER

Finances

Share Ownership

Return on Equity

0,29 %

Current Ratio

4,56

Debt-to-Equity Ratio

0,01

Key figures (NOK)	2022	2021	2020	2019
Revenue	96 866 000	131 763 000	166 250 000	150 619 000
Net Income	258 000	−332 000	37 588 000	37 325 000
Total Assets	106 760 000	125 008 000	143 947 000	153 954 000
Total Equity	88 050 000	113 674 000	114 006 000	76 418 000

Income (NOK)	2022	2021	2020	2019
Revenue	96 866 000	131 763 000	166 250 000	150 619 000
Expenditure	115 447 000	140 890 000	149 104 000	133 734 000
Operating Profit	−18 582 000	−9 128 000	17 146 000	16 886 000
Financial Income	29 725 000	12 200 000	36 824 000	28 705 000
Financial Costs	3 336 000	3 404 000	14 318 000	4 874 000
Financial Balance	26 389 000	8 796 000	22 506 000	23 831 000
Earnings Before Tax	7 807 000	−332 000	39 652 000	40 718 000
Tax	7 548 000	0	2 064 000	3 393 000
Net Income	258 000	−332 000	37 588 000	37 325 000

Balance (NOK)	2022	2021	2020	2019
Total Fixed Assets	24 513 000	58 041 000	76 588 000	84 920 000
Total Current Assets	82 247 000	66 967 000	67 359 000	69 034 000
Total Assets	106 760 000	125 008 000	143 947 000	153 954 000
Total Retained Equity	87 950 000	113 574 000	113 906 000	76 318 000
Total Equity	88 050 000	113 674 000	114 006 000	76 418 000
Total Long-Term Debt	690 000	617 000	4 022 000	5 556 000
Total Current Debt	18 020 000	10 717 000	25 920 000	71 981 000
Total Equity and Debt	106 760 000	125 008 000	143 947 000	153 954 000

Cash flow (NOK)	2022	2021	2020	2019
Sales Income	94 504 000	128 357 000	158 170 000	140 609 000
Other Income	2 362 000	3 406 000	8 081 000	10 011 000
Revenue	96 866 000	131 763 000	166 250 000	150 619 000
Cost of Goods Sold	37 552 000	48 146 000	63 537 000	47 367 000
Salary Costs	7 070 000	6 757 000	6 112 000	8 679 000
Depreciation	150 000	6 143 000	9 116 000	10 714 000
Impairment	0	0	0	0
Expenditure	115 447 000	140 890 000	149 104 000	133 734 000
Operating Profit	−18 582 000	−9 128 000	17 146 000	16 886 000
Financial Income	29 725 000	12 200 000	36 824 000	28 705 000
Financial Costs	3 336 000	3 404 000	14 318 000	4 874 000
Financial Balance	26 389 000	8 796 000	22 506 000	23 831 000
Dividends	25 881 000	0	0	0
Net Income	258 000	−332 000	37 588 000	37 325 000

Balance details (NOK)	2022	2021	2020	2019
Goodwill	0	0	0	0
Total Intangible Assets	0	7 548 000	7 548 000	9 612 000
Real Eastate	0	0	0	0
Machinery and Plant Facilities	0	0	0	0
Fixtures	140 000	238 000	9 694 000	13 605 000
Total Tangible Assets	140 000	238 000	9 694 000	13 605 000
Total Fiancial Fixed Assets	24 374 000	50 255 000	59 346 000	61 703 000
Total Fixed Assets	24 513 000	58 041 000	76 588 000	84 920 000
Stock	11 278 000	13 019 000	12 609 000	13 084 000
Total Investments	0	0	0	0
Cash, Bank	232 000	216 000	186 000	370 000
Total Current Assets	82 247 000	66 967 000	67 359 000	69 034 000
Total Assets	106 760 000	125 008 000	143 947 000	153 954 000
Total Equity	88 050 000	113 674 000	114 006 000	76 418 000
Short-Term Group Debt	0	0	0	0
Total Long-Term Debt	690 000	617 000	4 022 000	5 556 000
Creditors	11 041 000	2 248 000	7 840 000	2 671 000
Unpaid Taxes	5 877 000	7 932 000	8 282 000	7 181 000
Dividends	25 881 000	0	0	0
Other Current Debt	1 102 000	537 000	9 798 000	62 128 000
Total Current Debt	18 020 000	10 717 000	25 920 000	71 981 000
Total Equity and Debt	106 760 000	125 008 000	143 947 000	153 954 000

Financial indicators	2022	2021	2020	2019
Return on Equity	0,29 %	−0,29 %	32,97 %	48,84 %
Debt-to-Equity Ratio	0,01	0,01	0,04	0,07
Operating Profit Margin	−19,18 %	−6,93 %	10,31 %	11,21 %
Current Ratio	4,56	6,25	2,6	0,96
Quick Ratio	12,2	−29,09	5,06	1,17
Equity Ratio	0,82	0,91	0,79	0,5
Gross Profit Margin	61,23 %	63,46 %	61,78 %	68,55 %